Literature DB >> 29788135

The Hepatic Glucocorticoid Receptor Is Crucial for Cortisol Homeostasis and Sepsis Survival in Humans and Male Mice.

Marc Jenniskens1, Ruben Weckx1, Thomas Dufour1, Sarah Vander Perre1, Lies Pauwels1, Sarah Derde1, Arno Téblick1, Fabian Güiza1, Greet Van den Berghe1, Lies Langouche1.   

Abstract

Sepsis is hallmarked by hypercortisolemia, a stress response essential for survival. This elevation in plasma cortisol is partially brought about by suppressed hepatic cortisol breakdown. We demonstrate that a controlled downregulation of the hepatic glucocorticoid receptor (hepatic GR) is crucial. In a mouse model of fluid-resuscitated, antibiotic-treated abdominal sepsis and in human intensive care unit patients, sepsis reduced hepatic GR expression and signaling but increased (free) plasma cortisol/corticosterone, explained by suppressed cortisol/corticosterone-binding proteins and A-ring reductases. However, further experimental inhibition of hepatic GR with short hairpin RNA (shRNA) in septic mice increased mortality fivefold. Acutely, this further hepatic GR suppression prevented the rise in total corticosterone but further reduced binding proteins, resulting in elevated free corticosterone. After 3 days of shRNA-GR inhibition in sepsis, both total and free corticosterone levels were elevated, now explained by an additional reduction in A-ring reductase expression. Hepatic GR inhibition blunted the hyperglycemic stress response without causing hypoglycemia but also markedly increased circulating and hepatic inflammation markers and caused liver destruction, the severity of which explained increased mortality. In human sepsis, glucocorticoid treatment further suppressed hepatic GR expression, which could directly predispose to worse outcomes. In conclusion, sepsis partially suppressed hepatic GR expression, which appeared crucial to upregulate free cortisol/corticosterone availability. However, further sustained hepatic GR suppression evoked lethal excessive liver and systemic inflammation, independent of systemic cortisol/corticosterone availability.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29788135     DOI: 10.1210/en.2018-00344

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  CIRMI-a new term for a concept worthy of further exploration: a narrative review.

Authors:  Gladness Dakalo Nethathe; Jeffrey Lipman; Ronald Anderson; Charles Feldman
Journal:  Ann Transl Med       Date:  2022-06

Review 2.  Adrenal function and dysfunction in critically ill patients.

Authors:  Arno Téblick; Bram Peeters; Lies Langouche; Greet Van den Berghe
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

3.  Reprogramming of glucocorticoid receptor function by hypoxia.

Authors:  Tineke Vanderhaeghen; Steven Timmermans; Deepika Watts; Ville Paakinaho; Melanie Eggermont; Jolien Vandewalle; Charlotte Wallaeys; Lise Van Wyngene; Kelly Van Looveren; Louise Nuyttens; Sylviane Dewaele; Joke Vanden Berghe; Kelly Lemeire; Joey De Backer; Laura Dirkx; Wim Vanden Berghe; Guy Caljon; Bart Ghesquière; Karolien De Bosscher; Ben Wielockx; Jorma J Palvimo; Rudi Beyaert; Claude Libert
Journal:  EMBO Rep       Date:  2021-10-26       Impact factor: 8.807

4.  Letter to the Editor: "Our Response to Covid-19 as Endocrinologists and Diabetologists".

Authors:  Steven Snyder
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

5.  The Role of Glucocorticoid Receptor and Oxytocin Receptor in the Septic Heart in a Clinically Relevant, Resuscitated Porcine Model With Underlying Atherosclerosis.

Authors:  Tamara Merz; Nicole Denoix; Daniela Wigger; Christiane Waller; Martin Wepler; Sabine Vettorazzi; Jan Tuckermann; Peter Radermacher; Oscar McCook
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-14       Impact factor: 5.555

6.  Transcriptome Responses to Dexamethasone Depending on Dose and Glucocorticoid Receptor Sensitivity in the Liver.

Authors:  Eduard Murani; Nares Trakooljul; Frieder Hadlich; Siriluck Ponsuksili; Klaus Wimmers
Journal:  Front Genet       Date:  2019-06-12       Impact factor: 4.599

Review 7.  Impact of downstream effects of glucocorticoid receptor dysfunction on organ function in critical illness-associated systemic inflammation.

Authors:  Martin Wepler; Jonathan M Preuss; Tamara Merz; Oscar McCook; Peter Radermacher; Jan P Tuckermann; Sabine Vettorazzi
Journal:  Intensive Care Med Exp       Date:  2020-12-18

Review 8.  Sepsis as a Pan-Endocrine Illness-Endocrine Disorders in Septic Patients.

Authors:  Weronika Wasyluk; Martyna Wasyluk; Agnieszka Zwolak
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

Review 9.  Glucocorticoids in Sepsis: To Be or Not to Be.

Authors:  Jolien Vandewalle; Claude Libert
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

10.  ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study.

Authors:  Bram Peeters; Philippe Meersseman; Sarah Vander Perre; Pieter J Wouters; Yves Debaveye; Lies Langouche; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2018-10-29       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.